logo

Last Update

This profile was last updated on 9/18/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thomas Walsh?

Thomas J. Walsh

Director, Transplantation - Oncology Infectious Diseases Program

Cornell University

HQ Phone:  (607) 254-4636

Direct Phone: (212) ***-****direct phone

Email: t***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cornell University

159 Sapsucker Woods Rd

Ithaca, New York, 14850

United States

Company Description

Located in Ithaca, NY, Cornell University is a private institution that was founded in 1865. Today, it consists of 14 different schools that operate under the umbrella of the university. Cornell ranks 15 on the list of best national universities, 16 on the lis...more

Find other employees at this company (52,830)

Background Information

Employment History

Director of the Transplantation - Oncology Infectious Diseases Program

Weill Cornell Medical College


Adjunct Faculty Positions

Johns Hopkins University


Adjunct Faculty Positions

University of Maryland


Chief, Immunocompromised Host Section

National Cancer Intelligence Network


Director of the Transplantation - Oncology Infectious Diseases Program In the Division of Infectious Diseases of the Department of Medicine

NewYork-Presbyterian Hospital


Editor

American Society for Microbiology


Senior Investigator, Chief, Immunocompromised Host Section, Pediatric Oncology Branch

National Institutes of Health


Affiliations

International Commission on the Taxonomy of Fungi

Member


iCo Therapeutics Inc

Strategic Advisory Board Member


International Immunocompromised Host Society

Councilor


Annals

Reviewer Or Member of the Editorial Board


Landes Bioscience

Advisory Board Member


Western Section AUA

Board Member


Education

University of Texas Health Science Center


M.D.


M.D. degree

Johns Hopkins University School of Medicine


MD

Univ. of Washington


medical degree

The John Hopkins University School of Medicine


Web References(159 Total References)


Research | Henry Schueler 41 & 9 Foundation

The Supplement was edited by Dr. Thomas Walsh, the Director of the Transplantation-Oncology Infectious Diseases Program at Cornell University Medical Center (Weill-Cornell Medical College and New York Presbyterian Hospital) in New York.
It is widely held as the most comprehensive and authoritative body of research on the subject of Mucormycosis in the world. In 2013, Dr. Walsh was also named as the Henry Schueler 41 & 9 Foundation Scholar. This title accompanies all of his correspondence, manuscripts, and other publications and confers greater public awareness of the Henry Schueler 41 & 9 Foundation and assists Dr. Walsh in pursuing the Foundation's mission in Mucormycosis. His mission and ours is to develop new strategies for diagnosis, treatment, and prevention of invasive Mucormycosis; increase public awareness of the epidemiology, morbidity and mortality of invasive Mucormycosis; and to provide expert outreach assistance to patients with Mucormycosis, their families, and their physicians.


Award Lectures

Thomas Walsh; Cornell Univ., Ithaca, NY


http://www.infectioncontroltoday.com/articles/2013/01/environmental-hygiene-tips-for-microfiber-other-healthcare-textile-use.aspx

Thomas J. Walsh, MD, FACP, director of Cornell University's transplantation-oncology infectious diseases program, has presented several studies on active barrier protective uniforms.
He explains, "Bacteria are highly adherent organisms. Look for a fabric that is designed to repel most fluids."(1) Fluid repellency stops organisms from sticking to fabrics so there are fewer germs on the on the fabric.(2) This also protects the wearer from unexpected sprays and splashes of dangerous substances. As Walsh adds, "The second mechanism of action may be direct antimicrobial effect of the disinfectant embedded into the fabric.


VESTEX :: In the News

Thomas J. Walsh, MD, FACP, director of Cornell University's transplantation-oncology infectious diseases program has presented four research posters on the new textile technologies.
Dr. Walsh explains, "Bacteria are highly adherent organisms. Dr. Walsh continues, "The second important mechanism of action is the possible direct antimicrobial effect of the antimicrobial agent imbedded into the fabric.


VESTEX :: In the News

It takes only a small amount of moisture, a little bit of grime or grease or dirt, which has a small amount of protein, and bacteria are very happy to proliferate," said conference speaker Thomas J. Walsh, FACP, director of Cornell University's transplantation-oncology infectious diseases program and part of the research team working on the new fabric, known as VTT-003 or by its trade name, VESTEX™.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory